Japan’s Largest Biocluster, Korean Ventures To Collaborate For Cell And Gene Therapies
MoU To Be Signed
Japan’s largest biopharma R&D hub has been in active discussions with Korean bioventures for possible collaboration in the cell and gene therapy area. The idea, also backed by the Korean government, started with a paradigm shift during the pandemic.
